FDA Drug recall D-1282-2020
Ethacrynic Acid Tablets USP, 25 mg, 100 Tablets per Bottle, Rx only, Distr. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724, NDC:…
- FDA Drug
- Class III
- terminated
- Published 2020-05-27
On 2020-05-27 the FDA classified a Class III recall of Ethacrynic Acid Tablets USP, 25 mg, 100 Tablets per Bottle, Rx only, Distr. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724, NDC:… by West Ward Columbus, citing failed Impurities/Degradation Specifications: Out of Specification for impurity 6 and total degradants.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1282-2020 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2020-05-13 |
| Published | 2020-05-27 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | West Ward Columbus |
| Distribution | US |
Product
Ethacrynic Acid Tablets USP, 25 mg, 100 Tablets per Bottle, Rx only, Distr. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724, NDC: 0054-0415-25.
Reason
Failed Impurities/Degradation Specifications: Out of Specification for impurity 6 and total degradants.
Identifiers
| code_info | Lot #: AA4424A, Exp. 07/31/2020 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1282-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.